Gentian Diagnostics AS (GENT) — Capital Reinvestment Ratio
Gentian Diagnostics AS (GENT) has a Capital Reinvestment Ratio of 0.25x as of December 2025, meaning it reinvests 0% of its operating cash flow (Nkr42.59 Million) in capital expenditures (Nkr10.76 Million). See GENT net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Gentian Diagnostics AS Capital Reinvestment Ratio (2013–2025)
This chart tracks Gentian Diagnostics AS's Capital Reinvestment Ratio across 4 annual periods. Check Gentian Diagnostics AS investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Gentian Diagnostics AS (2013–2025)
Year-by-year Capital Reinvestment Ratio for Gentian Diagnostics AS from 2013 to 2025. For live market cap and broader valuation context, see GENT company net worth.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | Nkr42.59 Million | Nkr10.76 Million | ▼ -69.0% |
| 2024 | 0.81x | Nkr13.46 Million | Nkr10.95 Million | ▲ +180.3% |
| 2023 | 0.29x | Nkr15.46 Million | Nkr4.49 Million | ▼ -79.8% |
| 2013 | 1.44x | Nkr2.43 Million | Nkr3.49 Million | — |